Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05957653 | Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort | unknown | Phase 4 | 140 | RenJi HospitalOTHER | 0 | Jul 24, 2023 | clinicaltrials |
| NCT03796195 | (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes | terminated | Phase 4 | 1 | Northwestern UniversityOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT03971110 |
| A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy. |
| terminated |
| Phase 4 |
| 9 |
| AstraZenecaINDUSTRY |
| 1 |
| Dec 16, 2022 |
| clinicaltrials |
| NCT05631080 | Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer | unknown | Phase 4 | 50 | Mansoura UniversityOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT03228108 | Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.(pro-SWAP) | completed | Phase 4 | 1,538 | Radboud University Medical CenterOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT05304169 | Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.(PRIZE) | completed | Phase 4 | 48 | Zodiac Produtos Farmaceuticos S.A.INDUSTRY | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02726009 | A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer | completed | Phase 4 | 230 | Ferring PharmaceuticalsINDUSTRY | 1 | Dec 15, 2021 | clinicaltrials |
| NCT05068180 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | unknown | Phase 4 | 200 | RenJi HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04248621 | Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients | unknown | Phase 4 | 164 | Wonju Severance Christian HospitalOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT04882618 | Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. | unknown | Phase 4 | 50 | TC Erciyes UniversityOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT01753297 | A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.(PRIORITI) | completed | Phase 4 | 226 | IpsenINDUSTRY | 2 | Dec 9, 2020 | clinicaltrials |
| NCT02721433 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases(REaCT-BTA) | completed | Phase 4 | 263 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT03006562 | PREvention of VENous ThromboEmbolism Following Radical Prostatectomy(PREVENTER) | terminated | Phase 4 | 501 | Johns Hopkins UniversityOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT02812186 | Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery | completed | Phase 4 | 79 | Stony Brook UniversityOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT02475057 | Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists | completed | Phase 4 | 80 | Rabin Medical CenterOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT00906269 | Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer(HBOT) | unknown | Phase 4 | 100 | Hartford HospitalOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03831321 | The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy | unknown | Phase 4 | 144 | Taha UçarOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT01136226 | Evaluate Recovery of Testosterone for Patients Using Eligard(Eligard) | completed | Phase 4 | 42 | Chesapeake Urology Research AssociatesOTHER | 0 | Oct 24, 2018 | clinicaltrials |
| NCT02818816 | Preoperative Brimonidine on IOP of Patients Undergoing RALP(IOPsTBURG) | completed | Phase 4 | 26 | University Health Network, TorontoOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT00859027 | Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer | completed | Phase 4 | 50 | UConn HealthOTHER | 1 | May 1, 2018 | clinicaltrials |
| NCT02441517 | A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment | terminated | Phase 4 | 4 | Astellas Pharma Global Development, Inc.INDUSTRY | 1 | Apr 19, 2018 | clinicaltrials |
| NCT02025361 | Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy | completed | Phase 4 | 422 | Bagcilar Training and Research HospitalOTHER_GOV | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01296672 | 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer | completed | Phase 4 | 383 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00063609 | The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy | completed | Phase 4 | 200 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT03202381 | Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix(BLADE) | unknown | Phase 4 | 35 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jun 28, 2017 | clinicaltrials |
| NCT00219271 | Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer | completed | Phase 4 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 31, 2017 | clinicaltrials |
| NCT01230905 | Study to Monitor the Effects of Androgen Suppression Treatment on the Heart(AST) | completed | Phase 4 | 181 | Ottawa Heart Institute Research CorporationOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT01933022 | A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease(EFFECT) | terminated | Phase 4 | 1 | Astellas Pharma Europe Ltd.INDUSTRY | 1 | Mar 9, 2017 | clinicaltrials |
| NCT00470834 | Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy | completed | Phase 4 | 127 | GlaxoSmithKlineINDUSTRY | 2 | Feb 27, 2017 | clinicaltrials |
| NCT00237146 | Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy | completed | Phase 4 | 38 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00242554 | Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases | completed | Phase 4 | 150 | Novartis PharmaceuticalsINDUSTRY | 0 | Feb 23, 2017 | clinicaltrials |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | completed | Phase 4 | 411 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02441894 | Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer(PEGAZUS) | completed | Phase 4 | 21 | SanofiINDUSTRY | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00375765 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | completed | Phase 4 | 40 | GlaxoSmithKlineINDUSTRY | 1 | Jan 19, 2017 | clinicaltrials |
| NCT00363311 | Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men | completed | Phase 4 | 302 | GlaxoSmithKlineINDUSTRY | 2 | Jan 18, 2017 | clinicaltrials |
| NCT01571544 | The Use of Thermal Suits as Preventing Hypothermia During Surgery | completed | Phase 4 | 100 | Tampere University HospitalOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT00391690 | Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | completed | Phase 4 | 99 | NovartisINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00220194 | A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer | completed | Phase 4 | 100 | San Bernardino Urological Associates Medical Group IncOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01649635 | Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer(PROSPECTA) | completed | Phase 4 | 45 | SanofiINDUSTRY | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02773251 | The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery | completed | Phase 4 | 60 | Bucheon St. Mary's HospitalOTHER | 0 | May 17, 2016 | clinicaltrials |
| NCT02757365 | Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer | unknown | Phase 4 | 100 | West China HospitalOTHER | 1 | May 2, 2016 | clinicaltrials |
| NCT02749825 | Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | terminated | Phase 4 | 41 | PharmatechINDUSTRY | 1 | Apr 25, 2016 | clinicaltrials |
| NCT01083199 | Global Performance Evaluation of the AMS CONTINUUM™ Device | completed | Phase 4 | 10 | American Medical SystemsINDUSTRY | 2 | Apr 12, 2016 | clinicaltrials |
| NCT01581749 | Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer | unknown | Phase 4 | 50 | Albert DeNittisOTHER | 1 | Mar 23, 2016 | clinicaltrials |
| NCT02102646 | MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | completed | Phase 4 | 31 | Herlev HospitalOTHER | 1 | Oct 28, 2015 | clinicaltrials |
| NCT00629330 | Dissemination of Prostate Cancer Screening to PCP's in African American Communities | terminated | Phase 4 | 86 | Columbia UniversityOTHER | 0 | Oct 14, 2015 | clinicaltrials |
| NCT01511874 | Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer | completed | Phase 4 | 42 | HanAll BioPharma Co., Ltd.INDUSTRY | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02511665 | Metformin And Longevity(METAL) | unknown | Phase 4 | 185 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Jul 30, 2015 | clinicaltrials |
| NCT02149628 | The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide | completed | Phase 4 | 50 | Yonsei UniversityOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT00219219 | Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases | completed | Phase 4 | — | NovartisINDUSTRY | 1 | Apr 14, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Jul 24, 2023source: clinicaltrials